263 related articles for article (PubMed ID: 31376401)
21. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
[TBL] [Abstract][Full Text] [Related]
22. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
23. Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.
Kim W; Kang JA; Park M; Jeong PH; Kim YJ; Cho Y; Park SG; Kim YC
J Med Chem; 2021 May; 64(9):5500-5518. PubMed ID: 33887912
[TBL] [Abstract][Full Text] [Related]
24. The novel compound Z060228 inhibits assembly of the HBV capsid.
Guan H; Zhao G; Chen W; Wu G; Liu H; Jiang X; Li S; Wang LL
Life Sci; 2015 Jul; 133():1-7. PubMed ID: 25921762
[TBL] [Abstract][Full Text] [Related]
25. Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly.
Jeong H; Cho MH; Park SG; Jung G
FEBS Lett; 2014 Mar; 588(6):851-8. PubMed ID: 24462683
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
[TBL] [Abstract][Full Text] [Related]
27. SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators.
Kuduk SD; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2019 Aug; 29(16):2405-2409. PubMed ID: 31227344
[TBL] [Abstract][Full Text] [Related]
28. 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor.
Cho MH; Jeong H; Kim YS; Kim JW; Jung G
J Viral Hepat; 2014 Dec; 21(12):843-52. PubMed ID: 24372792
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.
Mani N; Cole AG; Phelps JR; Ardzinski A; Cobarrubias KD; Cuconati A; Dorsey BD; Evangelista E; Fan K; Guo F; Guo H; Guo JT; Harasym TO; Kadhim S; Kultgen SG; Lee ACH; Li AHL; Long Q; Majeski SA; Mao R; McClintock KD; Reid SP; Rijnbrand R; Snead NM; Micolochick Steuer HM; Stever K; Tang S; Wang X; Zhao Q; Sofia MJ
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555628
[TBL] [Abstract][Full Text] [Related]
30. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
[TBL] [Abstract][Full Text] [Related]
31. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay.
Pei Y; Wang C; Ben H; Wang L; Ma Y; Ma Q; Xiang Y; Zhang L; Liu G
ACS Infect Dis; 2019 May; 5(5):778-787. PubMed ID: 30761887
[TBL] [Abstract][Full Text] [Related]
32. The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.
Tan Z; Pionek K; Unchwaniwala N; Maguire ML; Loeb DD; Zlotnick A
J Virol; 2015 Mar; 89(6):3275-84. PubMed ID: 25568211
[TBL] [Abstract][Full Text] [Related]
33. Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.
Hurwitz SJ; McBrearty N; Arzumanyan A; Bichenkov E; Tao S; Bassit L; Chen Z; Kohler JJ; Amblard F; Feitelson MA; Schinazi RF
Viruses; 2021 Jan; 13(1):. PubMed ID: 33467678
[TBL] [Abstract][Full Text] [Related]
34. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
[TBL] [Abstract][Full Text] [Related]
35. Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
Ren Q; Liu X; Luo Z; Li J; Wang C; Goldmann S; Zhang J; Zhang Y
Bioorg Med Chem; 2017 Feb; 25(3):1042-1056. PubMed ID: 28082068
[TBL] [Abstract][Full Text] [Related]
36. Review of small synthetic molecules targeting HBV capsid assembly.
Liu N; Zhao F; Zhan P; Liu X
Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.
Zhang X; Cheng J; Ma J; Hu Z; Wu S; Hwang N; Kulp J; Du Y; Guo JT; Chang J
ACS Infect Dis; 2019 May; 5(5):759-768. PubMed ID: 30525438
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 70 and heat shock protein 90 synergistically increase hepatitis B viral capsid assembly.
Seo HW; Seo JP; Jung G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2892-2898. PubMed ID: 30115382
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein.
Liu H; Xi J; Hu J
J Virol; 2021 May; 95(12):. PubMed ID: 33789995
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
